Recommended Botulinum Toxin Dosage for Frontalis Muscle Treatment
The recommended dosage for botulinum toxin treatment of the frontalis muscle is 20 Units of onabotulinumtoxinA, administered as 4 Units (0.1 mL) into each of 5 sites across the forehead area. 1
Anatomical Considerations and Injection Technique
Optimal Injection Sites
- Lower Treatment Row: Position injections midway between the superior margin of frontalis activity and the eyebrow, at least 2 cm above the eyebrow
- Upper Treatment Row: Position injections midway between the superior margin of frontalis activity and lower treatment row
Specific Injection Points
- Place 5 injections at the intersection of the horizontal treatment rows with these vertical landmarks:
- On the lower treatment row at the midline of the face
- 0.5-1.5 cm medial to the palpated temporal fusion line (temporal crest) on each side
- On the upper treatment row, midway between the lateral and medial sites on the lower treatment row (both sides)
Safety Precautions
- Maintain at least 2 cm distance above the eyebrow to prevent brow ptosis
- Ensure proper identification of the superior margin of frontalis activity (approximately 1 cm above the most superior forehead crease)
- Administer injections with the needle perpendicular to the skin surface
Dosage Adjustments Based on Treatment Combinations
When treating the frontalis muscle in combination with other facial areas:
- Frontalis alone: 20 Units total
- Frontalis with glabellar lines: 40 Units total (20 Units for forehead, 20 Units for glabellar)
- Frontalis with glabellar and lateral canthal lines: 64 Units total (20 Units for forehead, 20 Units for glabellar, 24 Units for lateral canthal)
Anatomical Variations and Personalization
The frontalis muscle shows significant anatomical variation across patients, which affects treatment outcomes 2, 3:
- Forehead width: For wide foreheads (>70mm glabella-hairline distance), consider applying the toxin in three vertical lines in two split doses
- Forehead height: For narrow foreheads (<60mm glabella-hairline distance), consider applying the toxin in three horizontal lines in two split doses 4
Administration and Handling Precautions
- Healthcare providers should have epinephrine and antihistamine treatments available during administration
- Ensure proper storage at 2°C to 8°C (36°F-46°F) in the original carton to protect from light
- Do not freeze or shake the product 5
- Observe patients during administration as the risk of anaphylaxis is <2%
Potential Complications and Prevention
To minimize the risk of complications:
- Avoid injection near the levator palpebrae superioris
- Place lateral injections at least 1 cm above the bony supraorbital ridge
- Do not inject closer than 1 cm above the central eyebrow
- Keep injected volume/dose accurate and minimal where feasible 1
Expected Outcomes
- Chemical denervation typically begins 1-2 days after injection
- Maximum effect develops during the first week
- Duration of effect is approximately 3-4 months 1
- Treatment efficacy should be assessed by the patient's ability to activate the superficial muscles injected
The frontalis muscle requires careful assessment before treatment to achieve optimal cosmetic results while minimizing complications. The recommended 20 Units dosage provides an effective starting point, with adjustments based on individual anatomical variations and treatment goals.